UF neuroscientist to co-lead study into causes of frontotemporal dementia
Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.
Under new grant, a research team co-led by Dr. Malú Gámez Tansey will investigate possible links between the immune system and neurodegeneration in frontotemporal dementia.
The Harry T. Mangurian Jr. Foundation supported grants for two Lewy body dementia pilot studies.
Dr. Malú Tansey discusses new role as journal’s editor-in-chief, career path and research focus.
Neuroimmunologist Dr. Malú Tansey is highlighted in Knowable Magazine.
UF is collaborating on clinical trial testing if high-intensity treadmill exercise is effective in decreasing signs of Parkinson’s.
New study lends insights into factors that could help predict the efficacy of gene therapies using a genetically engineered antibody to target abnormal tau proteins.
CTRND researchers publish new paper in Journal of Neuroscience.
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
In new podcast, Dr. Malú Tansey discusses how her team helped lead the way in UF's efforts to bring researchers safely back to the lab.
Article in The Scientist featuring Dr. Malú Tansey examines COVID-19's impact on recruiting.